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Abstract 
Brain arteriovenous malformations (AVMs) are congenital vascular anomalies characterized by 
arteriovenous shunting through a network of coiled and tortuous vessels. Because of this anatomy, 
the venous drainage of an AVM is hypothesized to contain more oxygenated, arterialized blood than 
healthy veins. By exploiting the paramagnetic properties of deoxygenated hemoglobin in venous 
blood using magnetic resonance imaging (MRI) quantitative susceptibility mapping (QSM), we aimed 
to explore venous density and oxygen saturation (SvO2) in patients with a brain AVM.  
We considered three groups of subjects: patients with a brain AVM before treatment using gamma 
knife radiosurgery (GKR); patients three or more years post-GKR treatment; and healthy volunteers. 
First, we investigated the appearance of AVMs on QSM images. Then, we investigated whether QSM 
could detect increased SvO2 in the veins draining the malformations. 
In patients before GKR, venous density, but not SvO2, was significantly larger in the hemisphere 
containing the AVM compared to the contralateral hemisphere (p = 0.03). Such asymmetry was not 
observed in patients after GKR or in healthy volunteers. Moreover, in all patients before GKR, the 
vein immediately draining the AVM nidus had a higher SvO2 than healthy veins. Therefore, QSM can 
be used to detect SvO2 alterations in brain AVMs. However, since factors such as flow-induced signal 
dephasing or the presence of hemosiderin deposits also strongly affect QSM image contrast, AVM 
vein segmentation must be performed based on alternative MRI acquisitions, e.g., time of flight 
magnetic resonance angiography or T1-weighted images.  
This is the first study to show, non-invasively, that AVM draining veins have a significantly larger 
SvO2 than healthy veins, which is a finding congruent with arteriovenous shunting. 
Keywords 
Magnetic resonance imaging, quantitative susceptibility mapping, arteriovenous malformation, 
venous oxygen saturation, venous density  
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1. Introduction
2
 
Arteriovenous malformations (AVMs) are high-flow congenital vascular anomalies characterized by 
arteriovenous shunting with the lack of an intervening capillary bed. In an AVM, arteries and veins 
are directly connected through a network of coiled and tortuous vessels called a nidus (Friedlander, 
2007). In a healthy vascular network, the largest blood pressure drops occur in the capillary bed 
(Gould et al., 2017) whose hemodynamics and tortuous spatial organization enable a relatively 
uniform exchange of oxygen and nutrients between blood and the surrounding tissue. Therefore, in 
an AVM, the lack of capillaries causes the presence of mixed arterial and venous blood in the 
draining veins (Katayama et al., 1994) with higher velocity and often also higher pressure compared 
to healthy veins. The increased blood pressure, in particular, is a risk for vessel ruptures and 
hemorrhages (Friedlander, 2007). 
Selected cases of brain AVMs can be treated non-invasively using gamma knife radiosurgery (GKR), 
which uses a high dose of highly-focused gamma radiation to induce AVM obliteration with minimal 
damage to the surrounding tissue (Starke et al., 2017). On average, AVM obliteration occurs over a 
period of three years with reported success rates of 65% (Kano et al., 2012; Koltz et al., 2013; Starke 
et al., 2017). 
Digital subtraction angiography (DSA) is the gold standard imaging method for delineating the 
radiosurgical target before treatment with GKR (Pollock et al., 2011; Starke et al., 2017) and verifying 
the degree of success of GKR (Pollock et al., 2011). Magnetic resonance imaging (MRI) acquisitions 
have been used to gain additional information on the anatomy and location of brain AVMs 
compared to DSA. For example, it has been shown that the joint use of time-of-flight (TOF) magnetic 
resonance angiography (MRA) and DSA increases the accuracy of AVM nidus delineation (Bednarz et 
al., 2000; Rojas-Villabona et al., 2017). 
A further advantage of MRI over DSA is its potential to provide information on AVM 
pathophysiology. Because of their anatomy, the veins draining an AVM are expected to have a 
higher venous oxygen saturation (SvO2), which has been indirectly evidenced by the finding of “red 
veins” intraoperatively and by “downstream” jugular bulb oxygenation measurements (Katayama et 
al., 1994). Further indirect evidence suggesting altered oxygen exchange between blood flowing 
through an AVM and the surrounding tissue has been obtained using MRI arterial spin labeling (ASL) 
(Alsop et al., 2015). It has been shown (Kukuk et al., 2010; Le et al., 2012; Wolf et al., 2008) that the 
veins draining an AVM often appear unusually bright on an ASL image due to their residual 
unexchanged water content. However, the oxygenation of blood in veins immediately draining an 
                                                          
Abbreviations: AP, anterior-posterior; ASL, arterial spin labelling; AVM, arteriovenous malformation; DSA, 
digital subtraction angiography; DV, draining vein; FA, flip angle; FLIRT, FMRIB’s Linear Image Registration Tool; 
FSL, Oxford Centre for Functional MRI in the Brain Software Library; FoV, field of view; gad, gadolinium; GKR, 
gamma knife radiosurgery; GRE, gradient-recalled echo; ICBM, International Consortium for Brain Mapping; 
MIP, maximum intensity projection; MNI, Montréal Neurological Institute; MRI, magnetic resonance imaging; 
MRA, magnetic resonance angiography; MVF, multiscale vessel filtering; OEF, oxygen extraction fraction; PCA, 
phase contrast angiography; PET, positron emission tomography; PLIC, posterior limb of the internal capsule; 
REST, regional saturation technique; ROI, region of interest; RL, right-left; SD, standard deviation; SEM, 
standard error of the mean; SENSE, sensitivity encoding; SI, superior-inferior; SSS, superior sagittal sinus; SWI, 
susceptibility-weighted imaging; TE, echo time; TOF, time-of-flight; TR, repetition time; VIDA, Volumetric 
Image Data Analysis; QSM, quantitative susceptibility mapping. 
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AVM has never been directly or non-invasively measured. The magnetic susceptibility () of 
paramagnetic (i.e.,  > 0) deoxyhemoglobin in venous blood is proportional to SvO2 (Fan et al., 
2014; Jain et al., 2012; Spees et al., 2001; Weisskoff and Kiihne, 1992; Xu et al., 2014). Therefore, this 
study aimed to measure the SvO2 in veins directly draining brain AVMs non-invasively using 
quantitative susceptibility mapping (QSM) (Liu et al., 2009; Shmueli et al., 2009; Wang and Liu, 2015; 
Wharton and Bowtell, 2010). Moreover, by designing the gradient-recalled echo (GRE) protocol for 
QSM with a short first echo time (TE), this study aimed to assess whether the shortest TE magnitude 
image enabled visualization of in-flow effects in the arteries feeding the AVM nidus. If so, GRE 
protocols for QSM of vascular malformations could allow simultaneous acquisition of 
complementary arterial and venous contrasts. 
To enable MRI QSM measurement of SvO2 in an AVM’s draining veins, identifying these veins on a  
map is essential. The arteries feeding an AVM would not be expected to appear on a QSM image as 
arteries contain diamagnetic (i.e.,  < 0) fully oxygenated oxyhemoglobin, which does not cause a 
detectable  shift compared to the diamagnetic brain parenchyma (Duyn and Schenck, 2017; Jain et 
al., 2012). Similarly, because of their mixed content of arterial and venous blood, the veins draining 
an AVM would be expected to be less visible on a  map than healthy veins. 
The possibility of identifying brain AVMs and other vascular malformations on -based images has 
been demonstrated using susceptibility-weighted imaging (SWI) (Haacke et al., 2004). In previous 
studies, SWI helped delineate brain AVMs (Essig et al., 1999; Gasparotti et al., 2011; George et al., 
2010; Hodel et al., 2013; Huisman et al., 2010; Jagadeesan et al., 2011; Liu et al., 2015; Nabavizadeh 
et al., 2014; Reichenbach et al., 1998; Reichenbach and Haacke, 2001), arteriovenous fistulas 
(Gasparotti et al., 2011; Hodel et al., 2013; Jagadeesan et al., 2011; Nabavizadeh et al., 2014), 
capillary telangiectasias (Gelal et al., 2014; Lee et al., 1999; Tong et al., 2008), cavernous 
malformations (Dammann et al., 2013; Huisman et al., 2010; Knerlich-Lukoschus et al., 2015; Lee et 
al., 1999; Reichenbach et al., 2001; Thomas et al., 2008; Tong et al., 2008) and developmental 
venous anomalies (Fushimi et al., 2008; Horsch et al., 2014; Huisman et al., 2010; Liu et al., 2015; 
Reichenbach and Haacke, 2001; Thomas et al., 2008). A limitation of SWI is that it is purely a 
qualitative method because of the non-local nature and tissue geometry/orientation dependence of 
the GRE signal phase. Moreover, veins sometimes appear artifactually doubled on SWI, because of 
the dipole-like phase distributions around high- regions (Dymerska et al., 2018; Nissi et al., 2015). 
By calculating the underlying  distribution, QSM overcomes the non-locality and orientation-
dependence of tissue phase and SWI (Shmueli et al., 2009). Finally, a previous study using QSM (Liu 
et al., 2015) detected the presence of the abnormal vasculature of a brain AVM in one patient, but 
did not attempt to delineate single vessels draining the malformation or measure SvO2. 
In this study, we characterized the appearance of AVMs on susceptibility maps and measured -
based SvO2 in the AVM draining veins in two groups of patients before and after treatment with 
GKR. To enable comparison with normal appearing venous vasculature, we also compared the 
susceptibility maps and SvO2 measurements obtained in pre-GKR and post-GKR patients with those 
from healthy volunteers. 
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Parameter Sequence: 
Units 
(a) 2D GRE (b) 3D GRE (c) Gad-TOF 
MRA 
(d) Gad-T1-
weighted 
Pulse sequence 
type 
 GRE GRE GRE GRE 
Imaging type  2D 3D 3D 3D 
TE(s) ms 7.1, 13.4, 19.7, 
26, 32.3, 38.6, 
44.9, 51.2, 
57.6, 63.9 
3.43, 9.76, 16, 
22.4, 28.7, 35, 
41.4 
3.45 2.12 
TR ms 5635 46 25 25 
FA deg 90 17 20 or 25 30 
Acquisition time min:s 08:24 08:37 08:54 18:28 
Pixel Bandwidth Hz/pixel 217 210 216 157 
FoV mm
3
 240 x 180 x 144 246 x 184 x 144 250 x 250 x 50 210 x 210 x 150 
Acquired voxel 
size 
mm
3
 1 x 1 x 2 1.1 x 1.1 x 1.1 0.3 x 0.44 x 1 0.82 x 0.82 x 1.5 
Reconstructed 
voxel size 
mm
3
 1 x 1 x 2 1.1 x 1.1 x 1.1 0.13 x 0.13 x 0.5 0.82 x 0.82 x 1.5 
Acquisition 
matrix 
mm
3
 240 x 180 x 72 224 x 167 x 131 832 x 568 x 50 256 x 256 x 100 
Reconstruction 
matrix 
mm
3
 240 x 240 x 72 224 x 224 x 131 1936 x 1936 x 
100 
256 x 256 x 100 
Slice orientation - Transverse Transverse Transverse Transverse 
Phase encoding 
direction 
- RL RL RL RL 
Slice select (2D) 
/ partition 
encoding 
direction (3D) 
- SI SI SI SI 
Parallel imaging 
method 
- SENSE in the RL 
direction, 
factor = 2 
SENSE in the RL 
direction, 
factor = 2 
SENSE in the RL 
direction, factor 
= 2 
None 
Fat suppression - No No No No 
Brain coverage - Whole brain Whole brain Restricted to the 
AVM 
Whole brain 
Flow 
compensation 
- First TE, AP 
direction 
-  -  - 
Slab(s)  1 1 4 1 
REST slab - Yes No   
Post-contrast 
(gadolinium) 
- No No Yes Yes 
Table 1 Acquisition protocols for the study of brain AVMs. The table shows the 2D GRE (a), 3D GRE (b), gadolinium-
enhanced TOF MRA (c) and post-gadolinium T1-weighted (d) protocols used for the study of brain AVMs. 
2. Materials and methods 
Where not otherwise stated, the calculations and analyses were conducted in Matlab (R2017b, The 
MathWorks, Natick, MA, USA).  
2.1 Data and Code Availability Statement 
In compliance with the requirements of the funding bodies and the institutional ethics approval 
policies, the data and code that support the findings of this study are available from the 
corresponding author upon reasonable request.  
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2.2 Image Acquisition 
For this study, three groups of subjects were scanned: fifteen with a brain AVM before treatment 
with GKR (pre-GKR group, IDs: AVM01-15, average age/age range: 38/18-62 years, ten females), 
seventeen with a brain AVM treated using GKR at least three years before the scan (post-GKR group, 
IDs: GKR01-17, average age/age range: 37/16-70 years, nine females) and thirteen healthy 
volunteers (IDs: HV01-13, average age/age range: 33/22-54 years, four females).  
Three patients in the pre-GKR group had undergone partial glue embolization before the MRI 
examination, one of them on two occasions, and none of them had undergone surgical AVM 
excision. In the post-GKR group, there was a complete obliteration of the AVM after GKR except in 
four patients (GKR02, GKR04, GKR08 and GKR12). 
The patients in the pre-GKR group and the healthy volunteers were scanned on a Philips Achieva 3T 
system at the Queen Square Multiple Sclerosis Centre (UCL Institute of Neurology, London, UK) using 
a 32-channel radiofrequency head coil. The patients in the post-GKR group were scanned on a Philips 
Achieva 3T system at Verona University Hospital (Neuroradiology Unit, Department of Diagnostic 
and Pathology, Verona University Hospital, Verona, Italy) using an 8-channel radiofrequency head 
coil. 
The local ethics review boards approved all the scanning sessions and all subjects provided written 
informed consent. All the pre-GKR patients were scanned using a 3D multi-echo GRE protocol (Table 
1b) optimized for QSM of brain AVMs. Six post-GKR patients were also scanned using the same 3D 
protocol, whereas eleven post-GKR patients were scanned using a 2D multi-echo GRE protocol 
(Table 1a), which had been previously developed for 
∗ mapping. Of the thirteen healthy volunteers, 
ten were scanned using both the 2D and 3D GRE protocols, one with only the 3D protocol and two 
with only the 2D protocol. 
In this study, the images of two healthy volunteers (HV1-2) and two post-GKR patients (GKR04 and 
GKR09) were erroneously acquired with the transverse plane oblique (i.e., not perpendicular) to B0. 
Here, the image orientation was rotated to obtain alignment of the transverse imaging plane with 
the anterior-posterior commissure line. For these cases, the rotations needed to be accounted for in 
the QSM processing pipeline. 
In addition to the GRE protocols, both the pre-GKR and post-GKR patients were scanned using a 
gadolinium-enhanced TOF MRA protocol (gad-TOF MRA, see Table 1c for acquisition details). 
Additionally, the pre-GKR patients were scanned using a post-gadolinium T1-weighted protocol (gad-
T1-weighted, Table 1d). These two additional scans were designed as a part of a comprehensive 
protocol for MRI-based radiosurgical delineation of the AVM nidus before GKR (Rojas-Villabona et 
al., 2017). After the acquisition of 3D GRE images using the protocol shown in Table 1b, a manual 
intra-venous bolus injection of 0.2 mL/kg of Gadobenic acid 0.5 M (MultiHance, Milan, Italy) was 
performed over approximately 4 seconds followed by a saline flush of 20 ml. The gad-T1-weighted 
and gad-TOF MRA protocols were respectively started approximately 1 min and 11 min after the 
gadolinium injection. 
In addition to the imaging session, the pre-GKR patients underwent routine preoperative blood 
tests, including hematocrit measurements, which were performed at the same institution within 
three weeks before the MRI scan. 
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2.3 GRE Image Processing for QSM 
For both the 2D and 3D GRE data sets, a brain mask was calculated based on the first and last-TE 
magnitude images using the ITK-SNAP semi-automatic segmentation algorithm (Yushkevich et al., 
2006). Based on the first-TE magnitude image, care was taken to include the superior sagittal sinus 
(SSS) in the brain mask to allow measurement of healthy vein oxygenation. Based on the seventh-TE 
magnitude image, care was taken to exclude areas of susceptibility-induced signal loss at longer TEs 
caused by the air-tissue interface near the paranasal sinuses and mastoid air cells. For further details 
on the calculation of the brain mask for QSM see Section S1.1 and Fig. S1 in Supplementary Material. 
The processing pipeline for QSM included: temporal unwrapping and non-linear fitting (Liu et al., 
2013) of the complex GRE signal over multiple echoes; spatial phase unwrapping using Laplacian 
kernels (Schweser et al., 2013); background field removal using Projection onto Dipole Fields (Liu et 
al., 2011); local field-to-susceptibility inversion using Tikhonov regularization (Kressler et al., 2010); 
correcting for the underestimation of the regularized inverse magnetic dipole (Schweser et al., 
2013). For Tikhonov-based regularization and each GRE protocol (Table 1a and b), the optimal 
regularization parameter was calculated as the average across subjects of the individual optimal 
regularization parameters calculated using the L-curve method (Hansen and O’Leary, 1993). For 
further details on the choice of the local field-to-susceptibility inversion method and correction of  
underestimation see Section 1.2 and Fig. S2 in Supplementary Material. 
For the subjects in which the transverse plane of the FoV was not perpendicular to B0, the following 
steps were performed before background field removal, to correct for the tilted acquisition (Dixon, 
2018). First, the total field map was transformed from image to real world coordinates by resampling 
using the FSL Linear Image Registration Tool (FLIRT) (Jenkinson et al., 2012; Jenkinson and Smith, 
2001) with spline interpolation (Dixon, 2018). The brain mask and the total field noise map 
calculated by the non-linear fit algorithm were also rotated using FLIRT with trilinear and spline 
interpolation, respectively. 
QSM-based  measurements are inherently relative because of the removal of background fields, 
thus they should be referenced to a tissue region whose susceptibility is not highly variable between 
subjects to enable the comparison of SvO2 across subjects. Here, each  map was referenced to the 
posterior limb of the internal capsule (PLIC), which is a white matter region situated in the 
inferomedial part of each brain hemisphere. It has been shown (Straub et al., 2017) that  
measurements in the PLIC are nearly independent of age and have extremely small inter-subject 
variability. Thus, the PLIC was found to be the second-best region for  referencing after the 
cerebrospinal fluid (CSF) in the lateral ventricles. The advantage of considering the PLIC instead of 
the CSF is that the former can be delineated in a semi-automated fashion based on an anatomical 
template (Lim et al., 2013). In contrast, for the CSF, manual segmentation is required to exclude the 
choroid plexus, a structure located within the ventricles and made of epithelial cells, loose 
connective tissue and capillaries. 
For all patients and healthy subjects, the PLIC was automatically delineated based on the Eve 
susceptibility atlas (Lim et al., 2013). The Eve magnitude image was aligned to the skull-stripped 
fourth-echo magnitude image of all data sets, as the fourth TE was the closest to the TE of the Eve 
atlas (TEEve = 24 ms) in both the 3D (TE4,3D = 26 ms) and 2D (TE4,2D = 22.4 ms) GRE acquisitions (Table 
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1a and b). NiftyReg (Modat et al., 2010; Ourselin et al., 2001) was used to perform the 
coregistrations. 
Susceptibility referencing was achieved by calculating the mean value of  in the PLIC in both brain 
hemispheres and subtracting it from the  map. In three pre-GKR patients (AVM04, AVM11 and 
AVM14), the PLIC of only one brain hemisphere was considered (left for AVM11 and right for AVM04 
and AVM14), because in the contralateral hemisphere, the PLIC overlapped with the AVM or with 
paramagnetic hemosiderin deposits due to previous bleeding. 
2.4 Gad-TOF-MRA and Gad-T1-Weighted Image Processing 
In all the patients, both the gad-TOF MRA and gad-T1-weighted images were aligned with the first-
echo GRE magnitude image using the affine registration algorithm in NiftyReg (Modat et al., 2010; 
Ourselin et al., 2001). 
To improve visualization of the brain AVM, transverse maximum intensity projections (MIPs) of the 
coregistered gad-TOF MRA images were calculated for all the pre-GKR patients across slabs of five or 
ten slices for the 2D or 3D GRE images respectively. 
2.5 First-Echo GRE Magnitude Image Processing 
To investigate inflow effects, MIPs of the first-echo GRE magnitude image were calculated for all the 
patients across slabs of ten slices. In the first-echo magnitude images acquired using the 3D GRE 
acquisition, a TOF effect was expected to appear because of the short TE/TR. In the first-echo 
magnitude images acquired using the 2D GRE sequence, such a TOF effect was not expected to 
appear due to a combination of two factors: the longer TR values (i.e., 5636 ms compared with 46 
ms for 3D GRE) and the use of a regional saturation technique (REST) saturation slab to suppress 
inflow effects. To confirm these hypotheses on the appearance of inflow effects, the MIPs of the 
first-echo GRE magnitude images were compared to the images acquired using the gad-TOF MRA 
sequence (Table 1c) and their MIPs. 
2.6 Calculation of Susceptibility-Based Venograms 
Susceptibility-based venograms of all patients and healthy subjects were calculated using 
probabilistic multiscale vessel filtering (MVF) (Bazin et al., 2016). This method was chosen because it 
had been specifically designed to segment vessel-like structures from  maps.  
Two parameters can lead to significant changes in the resulting vessel segmentation using MVF: the 
threshold value for the vessel probability map and the number of scales for the width of the 
Gaussian kernel. Because there was no a priori information on the vessel anatomy, the probability 
threshold was set to its default value (i.e., 0.5). The maximum number of scales for the smoothing 
Gaussian kernel determines the maximum detectable size for a vessel on the  map. In a healthy 
subject, the average diameter of the largest cerebral veins is 4-5 mm (Durst et al., 2016). At the 
resolution of the 3D GRE protocol (i.e., 1.1 mm isotropic), assuming the absence of AVMs, large veins 
would be detected using four or more scales of the Gaussian kernel. Therefore, the optimal 
maximum number of scales was tested by applying MVF to the  maps of all pre-GKR patients with a 
maximum number of scales ranging from 4 to 10 in integer increments. 
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MVF with the parameters described above was applied to the  maps of all the patients and the 
healthy volunteers. To segment the veins in the  maps, the binary segmentation calculated using 
the MVF algorithm was multiplied by the corresponding  map.  
Transverse MIPs of the  maps, vein segmentations and segmented  maps were calculated to 
better appreciate and compare the vasculature. These MIPs were calculated across slabs of five or 
ten slices for 2D or 3D acquisitions respectively. 
2.7 Left and Right Brain Hemisphere Segmentation 
Masks for the left and right brain hemispheres (neurological convention) were created based on the 
Montréal Neurological Institute (MNI) International Consortium for Brain Mapping (ICBM) 2009c 
Nonlinear Symmetric Template with 1-mm isotropic resolution (Fonov et al., 2011; Fonov et al., 
2009). The brain mask provided with this template did not include the SSS. Therefore, this structure 
was added to the brain mask using ITK-Snap (Yushkevich et al., 2006) with a combination of semi-
automatic and manual segmentations. The resulting brain mask was then divided into left and right 
brain hemispheres by respectively isolating the regions to the left and right of the ICBM template's 
midline. 
To enable the alignment of the left and right hemisphere masks to each subject's  map, the gad-T1-
weighted magnitude image of the ICBM template was aligned to the fourth-echo GRE magnitude 
image of each subject using NiftyReg. The fourth-echo GRE magnitude image was chosen as the 
reference image because it had a contrast between adjacent brain structures that was similar to the 
gad-T1-weighted magnitude image of the ICBM atlas. A combination of rigid and deformable 
transformations was used (Modat et al., 2010; Ourselin et al., 2001). The resulting spatial 
transformation was then applied to each hemispheric brain mask. Finally, to remove voxels outside 
the corresponding  map, each coregistered hemispheric mask was multiplied by the same 3-voxel 
eroded brain mask used for QSM (Section 2.3). 
2.8 Calculation of Hemispheric Venous Densities 
Venous density was calculated in both brain hemispheres of all subjects as the ratio between the 
number of MVF-segmented "venous" voxels and the total number of voxels in the hemisphere. We 
aimed to assess if venous density could reflect the presence of a brain AVM. Therefore, in patients, 
venous density was compared in the hemisphere containing (pre-GKR) or once containing the AVM 
(post-GKR) and the contralateral hemisphere; in healthy volunteers, venous density was compared 
in the left and right hemispheres. 
The mean and SD of venous density and the inter-hemispheric difference of the venous density’s 
mean were calculated in all subjects and each hemisphere. Group-wise means and standard errors 
of the mean (SEMs) of the inter-hemispheric venous density difference were also calculated. The 
SEM was defined as the SD divided by the square root of the sample size, and it was chosen for 
group-wise analysis because it enabled comparing groups of different sizes.  
In the pre-GKR patients, to investigate the origin of potential venous density alterations in the 
presence of an AVM, Spearman's correlation coefficient was calculated between the venous density 
in the hemisphere containing the AVM and the volume of the AVM nidus. For each pre-GKR patient, 
the volume of the AVM nidus was calculated based on gold-standard DSA images acquired for GKR 
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planning and is reported in Inline Supplementary Table S1. The nidus volume was not available for 
one patient (AVM15), because they decided not to undergo GKR after DSA and MRI image 
acquisition. Therefore, in AVM15 the radiosurgical target was never delineated. Non-parametric 
Spearman's correlation was chosen due to the non-Gaussian distribution of the measured volumes 
and average venous densities. The significance of the correlation results was tested at a 5% 
significance level. 
In all groups, the significance of the inter-hemispheric difference in venous density was tested using 
a Wilcoxon rank sum test. This test was chosen due to the non-Gaussian distribution of the venous 
density values across subjects and was performed with a 5% significance level. In the pre-GKR 
patients, it was tested if venous density was larger in the hemisphere containing the AVM than in 
the contralateral hemisphere (one-tailed test). In the post-GKR patients with a successful AVM 
obliteration, the draining veins are expected to disappear as the AVM obliterates. Therefore, in this 
group it was tested if venous density was similar in the hemisphere that contained the AVM before 
GKR and the contralateral hemisphere (two-tailed test), first including then excluding the patients 
with a residual AVM (i.e., GKR02, GKR04, GKR08, and GKR12). In the healthy volunteers, it was 
tested if venous density was similar in the left and right brain hemispheres (two-tailed test). 
2.9 Calculation of Hemispheric SvO2 
SvO2 was calculated for all subjects in each MVF-segmented voxel according to (Bazin et al., 2016; 
Cetin et al., 2016; Fan et al., 2014; Fan et al., 2016; Ozbay et al., 2015; Serres et al., 2015; Weisskoff 
and Kiihne, 1992; Xu et al., 2014): 
SvO2 = 1 −
Δ − ΔHct
ΔHct
#!1"  
where Δ is the  shift between venous blood and water measured using QSM, 
Δ = 0.27 ⋅ 4'	ppm (Spees et al., 2001) the  shift per unit hematocrit (Hct) between fully 
deoxygenated and fully oxygenated red blood cells, and Δ = −0.03 ⋅ 4'	ppm (Weisskoff 
and Kiihne, 1992) the  shift per unit Hct between oxygenated red blood cells and water.  
In the pre-GKR patients, the individual measures of hematocrit (see Inline Supplementary Table S1) 
were used and as expected they were within normal limits. For subjects in which hematocrit 
measurements were not available (two pre-GKR patients and the whole post-GKR and healthy 
volunteer groups), a hematocrit value of 0.4 was assumed. 
For each subject, the mean and SD of SvO2 were calculated in each hemisphere. In addition, group 
means and SDs of SvO2 were calculated in the hemisphere with and without the AVM (patients) or in 
the left and right hemisphere (healthy volunteers). 
In the pre-GKR patients, to investigate the hemispheric distribution of SvO2, a histogram was 
calculated of the hemispheric SvO2 values in the MVF-segmented voxels. SvO2 values outside the 0-
100% range, which were mathematically admissible as a solution of Eq. 1 but non-physiological, 
were excluded from this analysis. Each histogram was fitted using a kernel smoothing function (for 
further details see Section S1.3 in Supplementary Material), and the local maxima of the fitted curve 
were calculated. If an AVM’s draining veins were correctly segmented in the venogram, a bimodal 
distribution of SvO2 was expected in the hemisphere containing the brain AVM, with the primary 
peak centered around the average SvO2 of healthy veins and a secondary peak centered around a 
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higher value of SvO2 measured in the AVM draining veins. In contrast, the SvO2 distribution in the 
hemisphere without the AVM was expected to only have one mode centered around the SvO2 value 
of healthy veins. 
Similar to the venous density analysis, in all groups the significance of the inter-hemispheric 
difference in SvO2 was tested using a non-parametric Wilcoxon rank sum test with a 5% significance 
level. In the pre-GKR patients, it was tested if SvO2 was larger in the hemisphere containing the AVM 
than in the contralateral hemisphere (one-tailed test). In the post-GKR patients, it was tested if SvO2 
was similar in the hemisphere that contained the AVM before GKR and in the contralateral 
hemisphere (two-tailed test) excluding the patients with a residual AVM (i.e., GKR02, GKR04, GKR08, 
and GKR12). In the healthy volunteers, it was tested if SvO2 was similar in the left and right brain 
hemispheres (two-tailed test). 
2.9 Selection of ROIs for Calculation of SvO2 in the AVM Draining Veins 
For each pre-GKR patient, three regions of interest (ROIs) were identified and drawn using ITK-
SNAP's active contour semi-automatic segmentation (Yushkevich et al., 2006).  
One ROI (ROIDV) was drawn on a vein directly draining the AVM. Such a draining vein was identified 
on the gad-TOF MRA image in consultation with a radiology clinical fellow (ARV) as the largest blood 
vessel linking the AVM nidus to a major venous drainage structure such as the venous sinuses or 
internal cerebral veins. ROIDV was delineated on the initial segment of the draining vein just after it 
left the AVM nidus. In one case, where the anatomy of the AVM's venous drainage was unclear from 
the gad-TOF MRA, the DSA image was reviewed by ARV to understand the draining pattern and 
confirm the location of the draining vein. ROIDV was drawn on the gad-TOF MRA image and had a 
different size for each patient due to the variable anatomy of the AVMs.  
Another ROI (ROISSS) was drawn on a region of the SSS that did not drain blood from the AVM, and, 
therefore, could be regarded as healthy. This ‘upstream’ portion of the SSS was drawn on the gad-T1-
weighted image, as, depending on the location of the AVM, the gad-TOF MRA image did not always 
include the SSS. For each patient, ROISSS was drawn on different locations of the SSS to ensure the 
exclusion of regions draining blood from the AVM. To provide a baseline SvO2 measurement in 
healthy veins while reducing the effect of partial voluming, for thirteen pre-GKR patients a third ROI 
(ROIHealthyVein2) was drawn on the gad-T1-weighted image in a healthy vein other than the SSS (for 
details, see Section S1.4 in Supplementary Material). 
All ROIs were aligned with the  map using the gad-TOF MRA and gad-T1-weighted to GRE image 
transformations calculated previously (Section 2.4). SvO2 was measured in each voxel of all ROIs 
using Eq. (1) with the same values for Δ, Δ and Hct described in Section 2.9. In each 
patient, the mean and SD of SvO2 were calculated in all ROIs. Moreover, the means and SEMs of 
SvO2 in all ROIs were calculated across patients. As the three venous ROIs had different sizes in 
individual patients, the SEM was chosen instead of the SD to enable the comparison of the variability 
of SvO2 across patients. Using a one-tailed Wilcoxon rank sum test (significance level = 5%), it was 
then tested if SvO2 in ROIDV was larger than in ROISSS. For further details on the calculation of a 
baseline SvO2 value in healthy veins and its comparison with an SvO2 value in draining veins see 
Section S1.4 in Supplementary Material.  
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Fig. 1 MVF segmentations for an increasing maximum number of scales. For a representative pre-GKR AVM patient, a 
sagittal and an axial slice of the  map (a) and the corresponding MVF segmentations are shown for an increasing 
maximum number of Gaussian filter scales (b-f). The arrows point at regions where the MVF segmentation was inaccurate 
for higher values of the maximum number of Gaussian filter scales. 
3. Results 
3.1 Parameter Optimization for Tikhonov-Based Regularization 
In the subjects scanned using the 3D and 2D GRE protocols (Table 1a and b), the average optimal 
regularization parameters for Tikhonov-based regularization were respectively equal to 0.0684 and 
0.0547. 
3.2 Parameter Optimization for Multiscale Vessel Filtering 
Fig. 1 shows the  map and the corresponding MVF segmentations of a representative pre-GKR 
patient with a small AVM in the cerebellum (not shown in these image slices). Because of the lack of 
a ground truth map of the venous vasculature, the accuracy of the segmentation could not be 
quantified. However, it was noted that on increasing the maximum number of scales the 
segmentation appeared increasingly noisy (Fig. 1, arrows on the sagittal slice). Moreover, on 
increasing the maximum number of scales, non-venous voxels were included into the final vein 
segmentation image, for example, in the paramagnetic deep gray matter nuclei (Fig. 1, arrows on 
the transverse slice). At the same time, increasing the number of maximum scales did not visibly 
improve the segmentation of larger veins as would be expected. Therefore, to minimize noise, it was 
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decided to apply the algorithm using a maximum of 4 scales for the Gaussian kernel, which 
corresponded to a maximum detectable vessel diameter of 4.4 mm along each imaging axis. 
 
Fig. 2 Multimodal imaging appearance of brain AVMs in four representative pre-GKR patients. The figure shows the same 
transverse slice of the coregistered gad-TOF MRA image (a) and the  map (b) and the same transverse slice (in a location 
similar to (a) and (b) of the MIP of the coregistered gad-TOF MRA (c), the MIP of the  map (d), the MIP of the first-TE GRE 
magnitude image (e) and the  map segmented using MVF (f). AVMs are circled in yellow. In subject AVM07, the white 
arrowhead points at an arterial structure in the AVM, whose presence was detected on the	 map. All images in columns 
(a), (c) and (e) are in arbitrary units and, in each column, the images are scaled within the same range. 
3.3 AVM Detection 
Fig. 2 shows that the features of a brain AVM are clearly identifiable in both the gad-TOF MRA 
images and MIPs (Figs. 2a and c);  maps and MIPs (Figs. 2b and d); and, to a lesser extent, in the 
first-TE GRE magnitude image (Fig. 2e).  
Fig. 3 shows that the previous presence of a brain AVM was detectable after GKR in three patients 
(GKR05, GKR06 and GKR13). The MIP of the first-echo GRE magnitude acquired using the 2D 
sequence did not contain TOF effects, which was expected because of the use of a REST slab the 
longer TR compared to the 3D sequence (Table 1). In contrast with the pre-GKR patients, the first-
echo GRE magnitude MIP in the post-GKR patients did not show bright AVM features (subjects 
GKR13 and GKR17 in Fig. 3e).  
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Notably, in both Figs. 2 and 3, some relatively large areas around the AVM appeared bright in the  
map (Figs. 3b and d) but not in the gad-TOF MRA image (Figs. 3a and c). Examples include the area 
circled in the images of patients AVM14 (fourth row in Figs. 2a-d) and GKR06 and GKR13 (fourth row 
in Figs. 3a-d). Bleeding can occur in the presence of an AVM due to rupture of the vessels caused by 
high blood pressure. Therefore, it is possible that these regions appeared bright only on the  
images because they contained paramagnetic hemosiderin deposits (Duyn and Schenck, 2017) from 
a previous bleed. 
 
Fig. 3 Multimodal imaging appearance of brain AVMs in four representative post-GKR patients. The figure shows the same 
transverse slice of the coregistered gad-TOF MRA image (a) and the  map (b) and the same transverse slice (in a location 
similar to (a) and (b)) of the MIP of the coregistered gad-TOF MRA (c), the MIP of the  map (d), the MIP of the first-TE GRE 
magnitude image (e) and the  map segmented using MVF (f). When identifiable, the area previously containing the AVM is 
circled in yellow. For QSM, patients GKR05 and GKR06 were scanned using the 2D GRE sequence, whereas patients GKR13 
and GKR17 were scanned using the 3D GRE sequence. All images in columns (a), (c) and (e) are in arbitrary units and, in 
each of these columns, the images are scaled within the same range. To allow direct comparison of the pre-GKR (Fig. 2) and 
post-GKR results, the gad-TOF MRA images (a) are scaled to the same range of values as in Fig. 2a. 
3.4 Hemispheric Venous Density 
In the pre-GKR patients (Fig. 4a), the hemisphere containing the AVM had the largest venous density 
in all patients except patient AVM12, who had a small AVM draining pattern (see size of ROIDV in 
Inline Supplementary Table S3). The mean and SD of the venous density across patients were both 
larger in the AVM-containing hemisphere (1.43 ± 0.45%) than in the hemisphere without the AVM 
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(1.15 ± 0.27%). The mean venous density was found to be significantly larger in the AVM-containing 
hemisphere than in the contralateral hemisphere (p = 0.03).  
 
Fig. 4 Hemispheric venous densities in the pre-GKR (a) and post-GKR patients (b) and healthy volunteers (c). Venous density 
values are shown for brain hemispheres with and without the brain AVM (a, b) and for the left and right hemispheres (c). In 
(b), the patient tags with a black diamond symbol denote the presence of residual AVM after GKR. 
In the post-GKR patients (Fig. 4b), the hemisphere that previously contained the AVM often had the 
largest venous density. Exceptions were observed in patients GKR06, GKR14 and GKR17. In line with 
the results of the pre-GKR patients, in the post-GKR patients with a residual AVM (i.e., GKR02, 
GKR04, GKR08 and GKR12) the hemisphere containing the AVM always had the largest venous 
density.  
In the post-GKR patients (Fig. 4b), the mean and SD of the venous density across all patients were 
slightly larger in the hemisphere that contained the AVM before GKR (1.18 ± 0.39%) than in the 
contralateral hemisphere (1.01 ± 0.24%). This same relationship was also observed excluding the 
four patients with residual AVMs, with slight changes in the means and SDs of the venous density in 
both the hemisphere that contained the AVM before GKR (1.12 ± 0.30%) and contralateral 
hemisphere (1.01 ± 0.26%). However, these hemispheric differences in venous density were not 
significant. 
In the healthy volunteers (Fig. 4a), the venous density had similar means and SDs in the left (1.09 ± 
0.22%) and right (1.04 ± 0.23%) hemispheres. Here, no significant difference was found between the 
venous density of the two brain hemispheres. 
The means and SEMs of the inter-hemispheric difference of venous density were larger in both the 
pre-GKR (0.29 ± 0.07%) and post-GKR patients (0.22 ± 0.07% or, excluding patients with a residual 
AVM, 0.18 ± 0.03%) than in the healthy volunteers (0.08 ± 0.01%). In the post-GKR patients with a 
residual AVM, the inter-hemispheric difference of venous density (mean and SEM: 0.36 ± 0.29%) was 
more similar to the corresponding value measured in the pre-GKR patients than in the post-GKR 
patients with successful GKR.  
According to the Wilcoxon rank sum test, the means of the inter-hemispheric difference of venous 
density were significantly different in both the pre-GKR (p = 0.048) and post-GKR patients (p = 0.01 
both including and excluding the subjects with a residual AVM) compared to the healthy volunteers. 
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Fig. 5 Correlation between the AVM's volume and the venous density in the brain hemisphere with the AVM in the pre-GKR 
patients. The correlation coefficient is reported on the top left corner of the scatter plot. 
A weak positive linear correlation (Fig. 5, correlation coefficient *+ = 0.44) was found between the 
volume of the AVM nidus and the venous density of the hemisphere containing the AVM in the pre-
GKR patients. However, the correlation between these two variables was not significant. 
3.5 Hemispheric SvO2 
For the referencing of the  maps, the mean ± SD of the  in the PLIC across all subjects was −0.01 ± 
0.02 ppm.  
In contrast with the hemispheric venous density results (Fig. 4), in the patients the hemispheric SvO2 
was not consistently larger in the hemisphere containing the AVM both before (see Inline 
Supplementary Fig. S3a) and after GKR (see Inline Supplementary Fig. S3b). As a result, no significant 
inter-hemispheric SvO2 difference was found in patients or healthy volunteers. Moreover, in both 
brain hemispheres, no significant difference was found between the hemispheric SvO2 in the AVM 
patients compared to the healthy volunteers. 
In the histogram analysis, only one meaningful local maximum of SvO2 was detected and it was 
always in the 70-80% range. If more local peaks were detected, these included only a few voxels 
with a much lower value of SvO2, e.g., 17% (see Inline Supplementary Fig. S4a). However, such small 
values of SvO2 are non-physiological, as gold-standard positron emission tomography (PET) 
measurements report SvO2 values around 60% (Bremmer et al., 2011; Hattori et al., 2004). 
Therefore, additional local maxima in the histograms did not indicate the presence of an AVM. Their 
presence was rather linked to noise in the hemispheric SvO2 distributions. Similar results were 
observed in the healthy volunteers and in the post-GKR patients.  
For further details on the hemispheric SvO2 results, see Section S2.1 in Supplementary Material. 
3.6 ROI-Based SvO2 
In the pre-GKR patients, the size of ROISSS and ROIDV varied across a considerably large range (see 
Inline Supplementary Table S3), reflecting the highly variable anatomy and location of brain AVMs 
across patients. For the calculation of ROI-based SvO2, 23 ± 19 and 33 ± 64 voxels were respectively 
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removed from ROISSS and ROIDV and because their corresponding SvO2 value was outside the 0-100% 
range. 
 
Fig. 6 AVM draining vein and SSS ROIs in four representative pre-GKR patients. The contour of the AVM draining vein ROI is 
shown overlaid on the same transverse slice of the gad-TOF MRA image (coregistered to the  map) (a) and the  map (b). 
Similarly, the contour of the SSS ROI is shown overlaid on the same sagittal slice of the gad-T1-weighted image (coregistered 
to the  map) (c) and the  map (d). All images in columns (a) and (c) are in arbitrary units and, in each of these columns, 
the images are scaled within the same range. These subjects are the same as those shown in Fig. 2: for patients AVM02 and 
AVM06 the same transverse slice is shown as in Fig. 2; for patients AVM07 and AVM14 a different transverse slice was 
chosen as the one shown in Fig. 2 did not include the draining vein ROI. 
ROIDV always delineated an area with a similar  to the surrounding brain tissue on the  maps (Fig. 
6b). In most pre-GKR patients, the region delineated by ROISSS appeared bright on the  map 
(AVM02, AVM06 and AVM07 in Fig. 6d). However, in four pre-GKR patients (AVM06, AVM08, AVM14 
in Fig. 6d and AVM15), the region delineated by ROISSS had a  similar to the surrounding brain 
tissue. 
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Fig. 7 ROI-based SvO2 measurements in the pre-GKR patients. For the pre-GKR patients, the figure shows the mean SvO2 
values measured in two ROIs: one drawn on the superior sagittal sinus (ROISSS) and the other on the largest vein draining 
the AVM (ROIDV). The error bars denote the SD of the measurements. 
SvO2 was always larger in ROIDV than in ROISSS (Fig. 7). The same relationship was also observed at a 
group level, as the means and SEMs of SvO2 across patients were equal to 75.41 ± 1.38% and 85.63 ± 
1.24% in ROISSS and ROIDV respectively. SvO2 was found to be significantly higher in ROIDV than in 
ROISSS (p < 0.001). For further details on the SvO2 results in ROIHealthyVein2 see Section S2.2 in 
Supplementary Material. 
4. Discussion 
This study aimed to evaluate the appearance of arteriovenous malformations (AVMs) on MRI-
derived quantitative susceptibility () maps, and compare venous vascularization and oxygenation in 
the brains of patients with an AVM before and after gamma knife radiosurgery (GKR) with healthy 
volunteers. In the QSM protocol, comparison of distinct strategies for performing local field-to-
susceptibility inversion enabled the calculation of  maps in which streaking artifacts were 
minimized. Therefore, streaking artifacts were not expected to significantly affect  measurements. 
In the pre-GKR patients, comparing  maps with gad-TOF MRA images acquired for high-resolution 
depiction of the AVM enabled evaluation of the AVM features appearing in  maps. This comparison 
also enabled investigation of whether the venous drainage of a brain AVM could be identified using 
-based vein segmentation. Similarly, in the post-GKR patients, comparing  maps with gad-TOF 
MRA images of the brain area containing the AVM before GKR allowed us to investigate whether 
scar tissue, paramagnetic hemosiderin deposits due to a previous hemorrhage, or residual AVM 
features could be detected on the  maps and how these might affect -based vein segmentation. 
To better explore these relationships, hemispheric venous density and oxygenation (SvO2) values 
were calculated using -based vein segmentations in AVM patients before and after treatment with 
GKR, and in healthy volunteers. Finally, in the pre-GKR patients, the comparison of SvO2 values in 
two venous ROIs allowed testing of the hypothesis that mixed arterial and venous blood draining 
from the AVM leads to increased SvO2 compared to healthy veins. 
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The AVM’s feeding arteries and nidus were not expected to appear in the susceptibility maps, 
because arterial blood and the surrounding brain parenchyma have a similar diamagnetic 
susceptibility. Moreover, in the pre-GKR patients the MRA-derived AVM nidus volume did not 
significantly correlate with the venous density in the hemisphere containing the malformation. 
Therefore, regions highlighted in the gad-TOF MRA images (Figs. 2a and c) and appearing bright in 
the  maps (Figs. 2b and d) could be AVM draining veins. However, the shape of the AVM features in 
the segmented  maps was dissimilar to the shape of the AVM veins visible in the gad-TOF MRA 
images (Figs. 2c, d and f). For example, the vessel highlighted on the gad-TOF MRA image of patient 
AVM07 (arrowhead on the gad-TOF image of patient AVM07 in Fig. 2a) was an artery but it was 
detectable on the  map (arrowhead on the  map of patient AVM07 in Fig. 2b). Therefore, 
susceptibility-based MVF segmentation of brain AVMs may have been influenced by additional 
factors. One confounder could be GRE signal dephasing induced by tortuous blood flow within the 
vessels in and around the AVM. For example, in patient AVM07 flow-induced dephasing inside an 
arterial structure (arrowhead on the gad-TOF image in Fig. 2b) and appearing bright on the  map 
(Fig. 2d) was erroneously segmented as venous by the MVF algorithm (Fig. 2f). The lack of flow 
compensation could have also contributed to decreasing the visibility of AVM draining veins, 
because in non-flow-compensated images veins usually appear displaced between echoes due to 
incorrect phase encoding of the GRE signal. On the other hand, the nonlinear fitting method used to 
combine multiple TEs may have mitigated potential errors due to flow effects. Indeed, this method 
assigns smaller weights to unexpected signal changes and regions of low signal-to-noise ratio, and 
has been shown to improve QSM image quality in both healthy veins and intracerebral hemorrhage 
(Liu et al., 2013). In some cases, bright regions on the  map could also be due to paramagnetic 
hemosiderin deposits from past bleeding or could be artifacts caused by a previous embolizing 
treatment. For example, the bright elongated shape on the  map of patient AVM14 (Figs. 2d and f) 
may have appeared because of the  difference between brain tissue and an area previously treated 
using embolizing glue. There are several embolizing agents available for the endovascular treatment 
of brain AVMs. One of the most frequently used is called Onyx (Medtronic Neurovascular, Irvine, CA, 
USA) and consists of ethylene vinyl alcohol copolymer, dimethyl-sulfoxide and tantalum powder 
(Vollherbst et al., 2018). Tantalum is a paramagnetic metal (Schenck, 1996) used to obtain 
radiopacity of the glue during treatment but also causing susceptibility artifacts on post-operative 
MRI (Cronqvist et al., 2006; Vollherbst et al., 2018). To avoid this limitation, new embolizing agents 
are being tested in which tantalum is replaced by other non-metallic radiopaque materials 
(Vollherbst et al., 2018). Therefore, in the future QSM of embolized brain AVMs could be unaffected 
by glue-induced  artifacts. 
In the pre-GKR patients, the AVM features appearing on the first-echo GRE magnitude image often 
reflected the shape of some AVM features appearing on the gad-TOF MRA (patients AVM02, AVM07 
and AVM14 in Fig. 2e). As the TOF effect highlights fast-flowing blood in both the 3D GRE first-TE 
magnitude image (Fig. 2e) and the MRA images (Figs. 2a and c) the regions appearing bright in both 
of these images were probably AVM feeding arteries or vessels in the AVM nidus expected to 
contain fast-flowing arterial blood. These results also demonstrate that GRE sequences for QSM can 
be tuned to obtain a TOF-sensitive contrast and therefore used for the simultaneous detection of 
arteries and veins. 
In the post-GKR patients, altered vessel anatomies were not detected in the first-TE 3D GRE 
magnitude image or in the MVF segmentation of the susceptibility maps because the nidus of an 
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AVM disappears following successful GKR (Fig. 3). Moreover, scar tissue due to AVM obliteration did 
not appear in the MVF segmentations indicating that the MVF algorithm could not identify features 
in the  image that would distinguish between scar tissue and the surrounding healthy brain tissue. 
Studies on automatic vein segmentation of SWI images (Beriault et al., 2015; Ward et al., 2018) have 
addressed the issue of potential false positives in the deep gray matter nuclei by incorporating 
anatomical templates of the basal ganglia as segmentation priors. Instead, the MVF algorithm 
applies a recursive ridge filter followed by a global probability diffusion approach, which enhances 
the filter response along connected components while removing unconnected ones. By tuning the 
parameters of the MVF algorithm, we effectively minimized the chance of false positives in 
paramagnetic deep grey matter regions (see Fig. 1). Past bleeding of an AVM represents an 
additional potential source of false positives in the MVF venograms, which was not explicitly 
addressed in this study. Instead, because hemorrhage linked to an AVM occurs around the 
malformation, false positives due to past bleeding were considered as a confounder potentially 
increasing the total venous density in the same hemisphere as the AVM. In this sense, hemorrhage 
represents a characteristic that may aid in the automatic identification of vascular malformations 
based on inter-hemispheric differences in venous density. Future work could explore the 
minimization of false positives due to hemorrhage in the MVF segmentation. This issue could be 
addressed by delineating and excluding areas of past bleeding from the  map before the 
application of MVF. It must be noted that such an approach would add a manual step to the 
otherwise automatic MVF algorithm, thus making the procedure for vein density estimation semi-
automatic.  
-based venograms of pre-GKR patients revealed a significant increase in venous density in the 
hemisphere containing the brain AVM (Fig. 4a) compared with the contralateral hemisphere. A 
similar but not significant increase in venous density was also observed in post-GKR patients (Fig. 
4b), whereas no increase was observed in healthy volunteers (Fig. 4c). The increased venous density 
in the patients indicates that the current or past presence of an AVM (and potential bleeding 
episodes associated to it) create ridges on the  map that are detectable using MVF. In the pre-GKR 
patients, a significant increase in the number of ridges on the  map could reflect the higher 
vascularization of AVMs compared to healthy tissue. AVM neovascularization is a dynamic process 
that occurs in response to hypoxia of the surrounding tissue and leads to AVM growth over time 
mainly via vasculogenesis, i.e., de novo formation of new vasculature (Lu et al., 2011). Ridges on the 
 maps of pre-GKR patients could also stem from confounding factors such as fast-flowing blood in 
the AVM’s arteries and hemosiderin deposits of a past hemorrhage in and around the AVM. Both of 
these factors were discussed earlier in this section. Because AVMs are expected to disappear after 
successful treatment, in the post-GKR patients, ridges on the  map could be caused by hemosiderin 
deposits from past bleeding or by previous embolizing treatment. The paramagnetic characteristics 
of embolizing agents were discussed earlier in this section. The significance of increased venous 
density only in untreated AVMs suggests that segmentation of susceptibility maps using MVF might 
offer valuable information for automated detection of brain vascular malformations. To facilitate 
this, it is recommended to set the size of the Gaussian smoothing filter to detect the largest 
diameter of healthy veins, as larger filter sizes led to more false positives in the MVF segmentations 
(Fig. 1) and the largest AVM draining veins were invisible on the  maps (Figs. 6a and b). The 
calculation of -based venous densities could be implemented as a screening tool for the automatic 
detection of vascular malformations in people undergoing MRI of the brain. In fact, incidental 
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findings of brain AVMs or cavernous malformations on MRI are relatively common with a prevalence 
of 0.05% and 0.16%, respectively (Morris et al., 2009). 
In the pre-GKR patients, the largest draining vein of an AVM segmented on the gad-TOF MRA image 
did not appear bright in the corresponding coregistered  map (Fig. 6) most likely because of the 
high oxygenation of blood in these vessels. Therefore, the veins draining an AVM should be 
segmented from alternative MRI acquisitions, e.g., gad-TOF MRA or gad-T1-weighted imaging, and 
the segmented vessels should be then coregistered to the image space of the  map. Such a 
segmentation could be facilitated by the use of a digital atlas of the venous cerebrovasculature. Such 
an atlas could also enable the automatic detection of anomalous vein anatomies based on MRA or 
-based images. Some studies have developed digital atlases of the brain vasculature including 
either the arteries (Dunas et al., 2017) or the veins (Ward et al., 2018). Others have developed such 
digital atlases including both the arteries and the veins with (Bernier et al., 2018; Huck et al., 2018) 
or without (Passat et al., 2005; Viviani, 2016) separate labelling for these two vessel types. Future 
work could explore the use of these probabilistic digital atlases of the cerebral vasculature in 
patients with a vascular malformation. This approach could help to highlight the presence of 
anomalous vascular components, defined as vessels appearing in areas where there is a low 
probability of observing a healthy vessel. 
No significant differences in the average hemispheric venous SvO2 were observed in or between any 
of the AVM patient groups or in the healthy volunteers. This result was expected in both healthy 
volunteers and GKR patients with successful AVM obliteration as their  maps did not contain any 
anomalous venous patterns. The similar SvO2 in the two hemispheres of the pre-GKR patients could 
be linked to the inaccurate MVF segmentation of the AVM draining pattern discussed above. It could 
also be due to a low proportion of AVM venous voxels compared to the total number of segmented 
venous voxels in the brain hemisphere containing the AVM. Both these hypotheses would also 
explain why only one SvO2 peak was observed in the histogram analysis of the hemispheric SvO2 (see 
Inline Supplementary Fig. S4). Because the brain parenchyma is diamagnetic, partial volume effects 
between veins and the surrounding brain tissue could also contribute to decrease the SvO2 
measured in the veins especially those with a diameter smaller than the acquired voxel size. The 
MVF algorithm mitigates partial volume effects by estimating the vessel diameters and using these 
to refine the vein segmentation. However, this approach does never fully remove partial voluming 
and it has been suggested (Bazin et al., 2016) that a future version of MVF could integrate the 
additional information on vein geometry and localization given by vascular trees or SWI. For the 
reduction of errors in  quantification induced by partial voluming, other strategies have been 
proposed (Fan et al., 2014; Hsieh et al., 2015; McDaniel et al., 2017; Ward et al., 2017) and are 
discussed later in this section. 
A negligible percentage (<1%) of voxels with erroneous SvO2 values were excluded from the analysis 
of hemispheric SvO2. Such incorrect SvO2 values were linked to incorrect  quantification in the 
corresponding voxels. In patients, this was possibly caused by the voxel’s proximity to paramagnetic 
embolizing glue, hemosiderin deposits or non--induced dephasing due to flow. In both patients and 
healthy subjects, these errors possibly derived from the MVF method mislabeling image ridges 
caused by head motion or sensitivity encoding (SENSE)-induced artifacts as vessels. 
The lack of  contrast between ROIDV and surrounding brain tissue in the pre-GKR patients (Fig. 6b) 
compared with other veins (e.g., the SSS) supports the hypothesis that blood with a higher 
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oxygenation than in healthy veins was collected by the AVMs’ draining pattern due to the presence 
of arteriovenous shunting. This hypothesis was also confirmed by our finding that the SvO2 was 
always higher in ROIDV than in ROISSS (Fig. 7) and that the difference between SvO2 in ROIDV and ROISSS 
was always higher than the difference between SvO2 in ROISSS and a distinct healthy vein ROI (see 
Inline Supplementary Fig. S5). This is the first time that SvO2 has been non-invasively and directly 
measured in the veins draining an AVM. 
Both the hemispheric SvO2 (see Inline Supplementary Fig. S3) and the SvO2 measured in ROISSS (Fig. 
7) and ROIHealthyVein2 in the pre-GKR patients (see Inline Supplementary Fig. S5) were always larger 
than SvO2 inferred from gold-standard PET measurements of oxygen extraction fraction (OEF), i.e., 
61 ± 6% (Hattori et al., 2004) or 57 ± 6% (Bremmer et al., 2011). It must be noted that OEF is the 
percentage of oxygen extracted from arterial blood:
 
OEF	 = SaO2-	SvO2#!2"  
where SaO2 is the arterial oxygen saturation and is assumed to be equal to 100%. SvO2 in the healthy 
veins of the pre-GKR patients (Fig. 7 and Inline Supplementary Fig. S5) was also often larger than 
recent QSM-based measurements in the same vein (Fan et al., 2014), i.e., 63.8 ± 3% across three 
healthy volunteers. Because of the inverse relationship between SvO2 and venous  (Eq. 1), this 
overestimation of SvO2 was most likely linked to an underestimation of venous . Several factors 
might have contributed to underestimating . Firstly, the lack of flow compensation in the GRE 
acquisitions might have introduced errors in the GRE phase measured in the veins. In fact, Fan et al 
(Fan et al., 2014) used a fully velocity-compensated multi-echo GRE sequence for QSM whereas our 
QSM sequence was not flow-compensated. Secondly, QSM may be less accurate than PET because it 
involves the solution of an ill-posed inverse problem and the use of regularization in the local field-
to-susceptibility inversion method leads to underestimation in itself. We attempted to address this 
last issue by applying a correction for  underestimation based on the point spread function of the 
modified dipole kernel (Schweser et al., 2013). However, in QSM the loss of information caused by 
the presence of zeros in the inverse magnetic dipole can never fully be recovered, and, even after 
correcting for  underestimation induced by regularization, a slight overestimation of SvO2 
compared to PET should always be expected. Thirdly, partial volume effects between veins and brain 
parenchyma at the boundaries of ROISSS and ROIDV might have inflated the SvO2 measurements. 
Several solutions have been proposed (Fan et al., 2014; Hsieh et al., 2015; McDaniel et al., 2017; 
Ward et al., 2017) to mitigate partial volume effects in venous ROIs. The two simplest approaches 
have involved either morphologically eroding the ROI or considering only the voxel with the 
maximum  value within the ROI (Fan et al., 2014). Both these approaches discard a large number of 
voxels from the ROI and therefore make the resulting  or SvO2 measurements highly sensitive to 
noise. Moreover, morphological erosion may leave few or no voxel in the ROI, especially in veins 
with a diameter of three voxels or fewer, which was the case of ROIDV and ROISSS in this study. 
Considering the maximum intensity voxel, instead, neglects information on potential regional  
variations due to gradients of oxygenation, whose exploration may be relevant in vascular disease. In 
alternative, other studies (Hsieh et al., 2015; McDaniel et al., 2017) have estimated and removed 
partial volume contributions from the affected voxels by modelling the complex GRE signal, whose 
phase component is sensitive to vein orientation. Such an approach, however, requires a vein to be 
parallel to the external magnetic field (McDaniel et al., 2017) or to not be tilted at the magic angle 
(Hsieh et al., 2015). To overcome limitations in vein orientation, another method (Ward et al., 2017) 
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has calculated a parametric map of partial voluming using	 values measured by QSM. It must be 
noted that all these three methods (Hsieh et al., 2015; McDaniel et al., 2017; Ward et al., 2017) have 
assumed that veins can be modelled as long and relatively straight cylinders, but this assumption 
cannot always be fulfilled by AVM draining veins. Therefore, partial volume correction remains an 
open problem in the case of nonstandard vessel anatomies, such as those found in vascular 
malformations, and further work is needed in this direction. Finally, it must be remarked that, as 
shown by in silico experiments (Ward et al., 2017), perfect removal of partial volume effects does 
not overcome  underestimation linked to the intrinsic limitations of the inverse problem solution in 
QSM. In this study, the potential influence of partial volume effects on ROI-based SvO2 
measurements was mitigated by comparing the difference in SvO2 between healthy and AVM 
draining veins with the difference in SvO2 between two healthy veins. This experiment could not be 
carried out in an optimal way, because the heterogeneity of AVM anatomy made it impossible to 
consider the same pair of healthy veins in all pre-GKR patients. However, it provided evidence that 
differences in SvO2 between healthy and AVM draining veins are linked to disease rather than being 
purely caused by partial volume effects or technical limitations of QSM. 
The benefit of using flow-compensated acquisition sequences for QSM of brain AVMs requires 
further investigation. Because of the tortuous nature of blood flow in and around the AVM, the 
assumptions underpinning conventional velocity compensation techniques (e.g., a plug flow model 
of venous blood flow) are probably violated in brain AVMs. One study (Ansari et al., 2013) using 
cardiac-gated and time-resolved 3D PCA has shown that both the feeding arteries and draining veins 
of a brain AVM are characterized by heterogeneous blood flow velocity distributions. In particular, 
venous blood flow velocities in an AVM’s draining veins are substantially higher (i.e., higher than 30-
50 cm/s) compared to normal venous velocities (i.e., 15-25 cm/s). Therefore, flow-induced  shifts 
may be substantial in AVM vessels. To gain insight into the complexity of blood flow in and around 
AVMs and reduce sources of  error due to turbulent flow, future work could involve building and 
imaging a blood flow phantom and analyzing previous results of studies of AVM hemodynamics 
(Ansari et al., 2013). This could enable improved flow compensation techniques for more accurate 
GRE imaging and QSM of brain AVMs. 
A further limitation of this study was the fact that the pre-GKR and post-GKR patient groups did not 
include the same subjects. Future work could involve scanning the patients of the pre-GKR cohort at 
least three years after treatment to confirm obliteration of the AVM and evaluate the effects of GKR 
on hemispheric venous density and SVO2 at an individual level. 
5. Conclusion 
We have shown that QSM is useful in the characterization of vascular abnormalities associated with 
AVMs. -based measures of hemispheric vessel density successfully differentiated brain 
hemispheres containing an AVM from the contralateral hemisphere. Therefore, similar 
measurements could be used as a tool for the -based detection of brain AVMs.  
Based on the intravascular  values, higher SvO2 was measured in the AVM draining veins than in 
healthy veins, demonstrating that QSM can detect SvO2 alterations in brain AVMs. This is the first 
study to non-invasively and directly measure SvO2 in the veins draining an AVM and to confirm the 
physiological hypothesis that blood flowing through the arteriovenous shunt is more oxygenated 
than blood in healthy veins. 
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